MORGAN STANLEY PLC/CALL/AMGEN/480/0.1/20.12.24 | Market Closed - Börse Stuttgart 03:24:47 2024-06-03 pm EDT | ||
| 0.197 EUR | +3.68% |
|
| Current month | +3.68% | ||
| 1 month | +1.55% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 0.197 | +3.68% |
| 24-05-31 | 0.19 | +7.95% |
| 24-05-30 | 0.176 | -4.35% |
| 24-05-29 | 0.184 | -6.12% |
| 24-05-28 | 0.196 | +3.70% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 03:24 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MB0FW5 |
| ISIN | DE000MB0FW54 |
| Date issued | 2022-11-10 |
| Strike | 480 $ |
| Maturity | 2024-12-20 (200 Days) |
| Parity | 10 : 1 |
| Emission price | 0.43 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.97 € |
|---|---|
| Lowest since issue | 0.087 € |
| Spread | 0.023 € |
| Spread % | 10.36% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.88%
- Stock Market
- Warrants
- Warrant
